880258 | C18:0 DG-PEG2K-triGalNAc
1,2-Dioctadecyl-sn-glycero-3N-[carboxy(polyethylene glycol)-2000]-N-tri(N-acetylgalactosamine)
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Application No. 63/776,541
Info
C18:0 DG-PEG2K-triGalNAc
1,2-Dioctadecyl-sn-glycero-3N-[carboxy(polyethylene glycol)-2000]-N-tri(N-acetylgalactosamine)
| C18:0 DG-PEG2K-triGalNAc is a functionalized PEG lipid that enhances targeted drug delivery by binding to the Asialoglycoprotein Receptor (ASGPR) which are predominantly found on the surface of liver cells. By functionalizing C18:0 DG-PEG2K with triGalNac, it allows this PEG lipid to be used in the formation of liposomes or LNPs that target the liver for drug delivery. |
Data
No
No
| C181H351N9O75 |
C 56.41%, H 9.18%, N 3.27%, O 31.14%
>99%
1 year
-20°C
3853.79
3851.39
Powered by Bioz
